Prevention of colorectal cancer remains our focus
There is a positive impact of an increase in adenoma detection rate (ADR) on the prevention of colorectal cancer (CRC)(*2). Supporting the identification of lesions, ENDO-AID CADe is designed to increase ADR(*3). We are aiming to increase the quality of CRC screening and its preventive efficacy against CRC. The prevention of CRC is a core element of Olympus' endeavors in medical endoscopy and beyond.
"With the launch of ENDO-AID, we are not only providing endoscopists across the world with an additional innovative tool," says Takaharu Yamada, Vice President, GI Endoscopy Business Leader, Endoscopic Solutions Division. "We are also preparing for the future and following our vision of putting CRC in the history books."
Official launch at United European Gastroenterology Week (UEGW)
During the virtual UEGW from October 11 to 13, ENDO-AID will be presented to the public for the first time. ENDO-AID is initially and commercially being launched in Europe beginning in November, followed shortly afterwards by some Middle Eastern, African and Asian-Pacific countries. Japan, the Americas and China markets will follow at a later time after complying with laws and regulations in each region. EVIS X1 and ENDO-AID are manufactured by Olympus Medical Systems Corporation. The company and product names specified in this release are the trademarks or registered trademarks of Olympus.
(*1) Product Name: Endoscopy CAD system
(*2) Corley, D.A.; Jensen, C.D.; Marks, A.R.; et al. Adenoma Detection Rate and Risk of Colorectal Cancer and Death. N Engl J Med. 2014; 370: 1298-1306. Available at: www.ncbi.nlm.nih.gov/pmc/articles/PMC4036494/. Accessed in October 2020
(*3) Compared to WLI (white light imaging) without CADe
About Olympus
Olympus is passionate about the solutions it creates for the medical, life sciences, and industrial equipment industries, as well as cameras and audio products. For more than 100 years, Olympus has focused on making people's lives healthier, safer, and more fulfilling by helping detect, prevent, and treat disease, furthering scientific research, ensuring public safety, and capturing images of the world.
Olympus Endoscopic Solutions uses innovative capabilities in medical technology, therapeutic intervention, and precision manufacturing to help healthcare professionals deliver diagnostic, therapeutic, and minimally invasive procedures to improve clinical outcomes, reduce overall costs, and enhance the quality of life for patients. Starting with the world's first gastrocamera in 1950, Olympus' endoscopic portfolio has grown to include endoscopes, laparoscopes, and video imaging systems, as well as systems integration solutions and medical services.
Back to HCB News
